Pathway Analysis of Differentially Expressed Genes in Patients with Acute Aortic Dissection
Biomarker Insights · 2009-01 · 4 · BMI.S2530
DOI: 10.4137/bmi.s2530 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomarker Insights, online erschienen am 06.05.2009. Verfasst von Salah A Mohamed und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac Surgery, University Clinic of Schleswig-Holstein, Campus Luebeck, Luebeck, Germany. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Acute aortic dissection (AAD) is a life-threatening condition with high mortality and a relatively unclarified pathophysiological mechanism. Although differentially expressed genes in AAD have been recognized, interactions between these genes remain poorly defined. This study was conducted to gain a better understanding of the molecular mechanisms underlying AAD and to support the future development of a clinical test for monitoring patients at high risk. Materials and Methods Aortic tissue was collected from 19 patients with AAD (mean age 61.7 ± 13.1 years), and from eight other patients (mean age 32.9 ± 12.2 years) who carried the mutated gene for Marfan syndrome (MS). Six patients (mean age 56.7 ± 12.3 years) served as the control group. The PIQOR™ Immunology microarray with 1076 probes in quadruplicates was utilized; the differentially expressed genes were analysed in a MedScan search using PathwayAssist software. Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) and protein analysis were performed.
Results
Interactions of MS fibrillin-1 (FBN1) in the MedScan pathway analysis showed four genes, fibulin-1 (FBLN1), fibulin-2 (FBLN2), decorin (DCN) and microfibrillar associated protein 5 (MFAP5), which were differentially expressed in all tissue from AAD. The validation of these genes by qRT-PCR revealed a minimum of three-fold downregulation of FBLN1 (0.5 ± 0.4 vs. 6.1 ± 2.3 fold, p = 0.003) and of DCN (2.5 ± 1.0 vs. 8.5 ± 4.7 fold, p = 0.04) in AAD compared to MS and control samples.
Conclusions
Downregulation of fibrillin-1 (FBN1) may weaken extracellular components in the aorta and/or interfer with the transmission of cellular signals and eventually cause AAD. Additional research on these four identified genes can be a starting point to develop a diagnostic tool.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiac Surgery, University Clinic of Schleswig-Holstein, Campus Luebeck, Luebeck, Germany.
Zitieren
APA
Mohamed, S. A., Sievers, H. H., Hanke, T., Richardt, D., Schmidtke, C., Charitos, E. I., Belge, G., & Bullerdiek, J. (2009). Pathway Analysis of Differentially Expressed Genes in Patients with Acute Aortic Dissection. Biomarker Insights, 4, BMI.S2530. https://doi.org/10.4137/bmi.s2530
Vancouver
Mohamed SA, Sievers HH, Hanke T, Richardt D, Schmidtke C, Charitos EI, et al. Pathway Analysis of Differentially Expressed Genes in Patients with Acute Aortic Dissection. Biomarker Insights. 2009;4:BMI.S2530. doi:10.4137/bmi.s2530
BibTeX
@article{Mohamed2009,
author = {Mohamed, Salah A and Sievers, Hans H and Hanke, Thorsten and Richardt, Doreen and Schmidtke, Claudia and Charitos, Efstratios I and Belge, Gazanfer and Bullerdiek, Joern},
title = {Pathway Analysis of Differentially Expressed Genes in Patients with Acute Aortic Dissection},
journal = {Biomarker Insights},
year = {2009},
volume = {4},
pages = {BMI.S2530},
doi = {10.4137/bmi.s2530}
}
EUVIMED